Skin sensitizers in cosmetics and beyond: potential multiple mechanisms of action and importance of T-cell assays for in vitro screening

References

• Adam J, Pichler WJ, Yerly D. 2011. Delayed drug hypersensitivity: models of T-cell stimulation. Br J Clin Pharmacol. 1:701–707.
   Web of Science ®Google Scholar
• Adam J, Wuillemin N, Watkins S, Jamin H, Eriksson KK, Villiger P, Fontana S, Pichler WJ, Yerly D. 2014. Abacavir induced T cell reactivity from drug naïve individuals shares features of allo-immune responses. PLoS One. 9:e95339.
   PubMed Web of Science ®Google Scholar
• Ade N, Martinozzi-Teissier S, Pallardy M, Rousset F. 2006. Activation of U937 cells by contact sensitizers: CD86 expression is independent of apoptosis. J Immunotoxicol. 3:189–197.
   PubMedGoogle Scholar
• Ahlfors SR, Sterner O, Hansson C. 2003. Reactivity of contact allergenic haptens to amino acid residues in a model carrier peptide, and characterization of formed peptide-hapten adducts. Skin Pharmacol Appl Skin Physiol. 16:59–68.
   PubMedGoogle Scholar
• Aleksic M, Pease CK, Basketter DA, Panico M, Morris HR, Dell A. 2007. Investigating protein haptenation mechanisms of skin sensitisers using human serum albumin as a model protein. Toxicol In Vitro. 21:723–733.
   PubMed Web of Science ®Google Scholar
• Alvarez-Sanchez R, Divkovic M, Basketter D, Pease C, Panico M, Dell A, Morris H, Lepoittevin JP. 2004. Effect of glutathione on the covalent binding of the 13C-labeled skin sensitizer 5-chloro-2-methylisothiazol-3-one to human serum albumin: identification of adducts by nuclear magnetic resonance, matrix-assisted laser desorption/ionization mass spectrometry, and nanoelectrospray tandem mass spectrometry. Chem Res Toxicol. 17:1280–1288.
   PubMed Web of Science ®Google Scholar
• American Academy of Dermatology and AAD Association. 1998. Position statement on the chemical identity of fragrances. Available from: https://www.aad.org/Forms/Policies/Uploads/PS/PS-Chemical%20Identity%20of%20Fragrances.pdf
   Google Scholar
• Api AM, Basketter D, Lalko J. 2015. Correlation between experimental human and murine skin sensitization induction thresholds. Cutan Ocul Toxicol. 34:298–302.
   PubMed Web of Science ®Google Scholar
• Aptula AO, Roberts DW, Pease CK. 2007. Haptens, prohaptens and prehaptens, or electrophiles and proelectrophiles. Contact Dermatitis. 56:54–56.
   PubMed Web of Science ®Google Scholar
• Arancioglu S, Ulker OC, Karakaya A. 2015. Utilization of the ex vivo LLNA: BrdU-ELISA to distinguish the sensitizers from irritants in respect of 3 end points-lymphocyte proliferation, ear swelling, and cytokine profiles. Int J Toxicol. 34:24–30.
   PubMed Web of Science ®Google Scholar
• Arase N, Arase H. 2015. Cellular misfolded proteins rescued from degradation by MHC class II molecules are possible targets for autoimmune diseases. J Biochem. 58:367–372.
   Web of Science ®Google Scholar
• Ariza A, Mayorga C, Fernandez TD, Barbero N, Martin-Serrano A, Perez-Sala D, Sanchez-Gomez FJ, Blanca M, Torres MJ, Montanez MI. 2015. Hypersensitivity reactions to β-lactams: relevance of hapten-protein conjugates. J Investig Allergol Clin Immunol. 25:12–25.
   PubMed Web of Science ®Google Scholar
• Ashikaga T, Sakaguchi H, Sono S, Kosaka N, Ishikawa M, Nukada Y, Miyazawa M, Ito Y, Nishiyama N, Itagaki H. 2010. A comparative evaluation of in vitro skin sensitisation tests: the human cell-line activation test (h-CLAT) versus the local lymph node assay (LLNA). Altern Lab Anim. 38:275–284.
   PubMed Web of Science ®Google Scholar
• Avonto C, Chittiboyina AG, Rua D, Khan IA. 2015. A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers. Toxicol Appl Pharmacol. 289:177–184.
   PubMed Web of Science ®Google Scholar
• Balmes JR, Abraham JL, Dweik RA, Fireman E, Fontenot AP, Maier LA, Muller-Quernheim J, Ostiguy G, Pepper LD, Saltini C, et al. 2014. An official American Thoracic Society statement: diagnosis and management of beryllium sensitivity and chronic beryllium disease. Am J Respir Crit Care Med. 190:e34–e59.
   PubMed Web of Science ®Google Scholar
• Basketter D, Alepee N, Casati S, Crozier J, Eigler D, Griem P, Hubesch B, de Knecht J, Landsiedel R, Louekari K, et al. 2013. Skin sensitisation-moving forward with non-animal testing strategies for regulatory purposes in the EU. Regul Toxicol Pharmacol. 67:531–535.
   PubMed Web of Science ®Google Scholar
• Basketter DA. 2009. The human repeated insult patch test in the 21st century: a commentary. Cutan Ocul Toxicol. 28:49–53.
   PubMed Web of Science ®Google Scholar
• Basketter DA, Clapp C, Jefferies D, Safford B, Ryan CA, Gerberick F, Dearman RJ, Kimber I. 2005. Predictive identification of human skin sensitization thresholds. Contact Dermatitis. 53:260–267.
   PubMed Web of Science ®Google Scholar
• Basketter DA, Evans P, Fielder RJ, Gerberick GF, Dearman RJ, Kimber I. 2002. Local lymph node assay – validation, conduct and use in practice. Food Chem Toxicol. 40:593–598.
   PubMed Web of Science ®Google Scholar
• Bauch C, Kolle SN, Ramirez T, Eltze T, Fabian E, Mehling A, Teubner W, van Ravenzwaay B, Landsiedel R. 2012. Putting the parts together: combining in vitro methods to test for skin sensitizing potentials. Regul Toxicol Pharmacol. 63:489–504.
   PubMed Web of Science ®Google Scholar
• Bell SJ, Pichler WJ. 1989. Penicillin-allergic patients react to penicillin-modified "self". Allergy. 44:199–203.
   PubMed Web of Science ®Google Scholar
• Bevan MJ. 1984. High determinant density may explain the phenomenon of alloreactivity. Immunol Today. 5:128–130.
   PubMedGoogle Scholar
• Buchli R, VanGundy RS, Hickman-Miller HD, Giberson CF, Bardet W, Hildebrand WH. 2005. Development and validation of a fluorescence polarization-based competitive peptide-binding assay for HLA-A*0201–a new tool for epitope discovery. Biochemistry. 44:12491–12507.
   PubMed Web of Science ®Google Scholar
• Call MJ. 2011. Small molecule modulators of MHC class II antigen presentation: mechanistic insights and implications for therapeutic application. Mol Immunol. 48:1735–1743.
   PubMed Web of Science ®Google Scholar
• Call MJ, Xing X, Cuny GD, Seth NP, Altmann DM, Fugger L, Krogsgaard M, Stein RL, Wucherpfennig KW. 2009. In vivo enhancement of peptide display by MHC class II molecules with small molecule catalysts of peptide exchange. J Immunol. 182:6342–6352.
   PubMed Web of Science ®Google Scholar
• Callan HE, Jenkins RE, Maggs JL, Lavergne SN, Clarke SE, Naisbitt DJ, Park BK. 2009. Multiple adduction reactions of nitroso sulfamethoxazole with cysteinyl residues of peptides and proteins: implications for hapten formation. Chem Res Toxicol. 22:937–948.
   PubMed Web of Science ®Google Scholar
• Cano P, Klitz W, Mack SJ, Maiers M, Marsh SG, Noreen H, Reed EF, Senitzer D, Setterholm M, Smith A, et al. 2007. Common and well-documented HLA alleles: report of the Ad-Hoc committee of the american society for histocompatiblity and immunogenetics. Hum Immunol. 68:392–417.
   PubMed Web of Science ®Google Scholar
• Castrejon JL, Berry N, El-Ghaiesh S, Gerber B, Pichler WJ, Park BK, Naisbitt DJ. 2010. Stimulation of human T cells with sulfonamides and sulfonamide metabolites. J Allergy Clin Immunol. 25:411–418. e414.
   Web of Science ®Google Scholar
• Cavani A. 2008. Immune regulatory mechanisms in allergic contact dermatitis and contact sensitization. Chem Immunol Allergy. 94:93–100.
   PubMedGoogle Scholar
• Cavani A, De Luca A. 2010. Allergic contact dermatitis: novel mechanisms and therapeutic perspectives. Curr Drug Metab. 11:228–233.
   PubMed Web of Science ®Google Scholar
• Chessman D, Kostenko L, Lethborg T, Purcell AW, Williamson NA, Chen Z, Kjer-Nielsen L, Mifsud NA, Tait BD, Holdsworth R, et al. 2008. Human leukocyte antigen class I-restricted activation of CD8+ T cells provides the immunogenetic basis of a systemic drug hypersensitivity. Immunity. 28:822–832.
   PubMed Web of Science ®Google Scholar
• Chew SL, Or MY, Chang CX, Gehring AJ, Bertoletti A, Grotenbreg GM. 2011. Stability screening of arrays of major histocompatibility complexes on combinatorially encoded flow cytometry beads. J Biol Chem. 286:28466–28475.
   PubMed Web of Science ®Google Scholar
• Chipinda I, Ajibola RO, Morakinyo MK, Ruwona TB, Simoyi RH, Siegel PD. 2010. Rapid and simple kinetics screening assay for electrophilic dermal sensitizers using nitrobenzenethiol. Chem Res Toxicol. 23:918–925.
   PubMed Web of Science ®Google Scholar
• Chittiboyina AG, Avonto C, Rua D, Khan IA. 2015. Alternative testing methods for skin sensitization: NMR spectroscopy for probing the reactivity and classification of potential skin sensitizers. Chem Res Toxicol. 28:1704–1714.
   PubMed Web of Science ®Google Scholar
• Clayton GM, Wang Y, Crawford F, Novikov A, Wimberly BT, Kieft JS, Falta MT, Bowerman NA, Marrack P, Fontenot AP, et al. 2014. Structural basis of chronic beryllium disease: linking allergic hypersensitivity and autoimmunity. Cell. 58:132–142.
   Web of Science ®Google Scholar
• Cluzel-Tailhardat M, Bonnet-Duquennoy M, de Queral DP, Vocanson M, Kurfurst R, Courtellemont P, Le Varlet B, Nicolas JF. 2007. Chemicals with weak skin sensitizing properties can be identified using low-density microarrays on immature dendritic cells. Toxicol Lett. 174:98–109.
   PubMed Web of Science ®Google Scholar
• Corsini E, Mitjans M, Galbiati V, Lucchi L, Galli CL, Marinovich M. 2009. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens. Toxicol In Vitro. 23:789–796.
   PubMed Web of Science ®Google Scholar
• Cottrez F, Boitel E, Auriault C, Aeby P, Groux H. 2015. Genes specifically modulated in sensitized skins allow the detection of sensitizers in a reconstructed human skin model. Development of the SENS-IS assay. Toxicol In Vitro. 29:787–802.
   PubMed Web of Science ®Google Scholar
• Daly AK, Donaldson PT, Bhatnagar P, Shen Y, Pe'er I, Floratos A, Daly MJ, Goldstein DB, John S, Nelson MR, et al. 2009. HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin. Nat Genet. 41:816–819.
   PubMed Web of Science ®Google Scholar
• Davis MM, Bjorkman PJ. 1988. T-cell antigen receptor genes and T-cell recognition. Nature. 334:395–402.
   PubMed Web of Science ®Google Scholar
• Dearman RJ, Cumberbatch M, Portsmouth C, Maxwell G, Basketter DA, Kimber I. 2008. Synergistic effects of chemical insult and toll-like receptor ligands on dendritic cell activation. Toxicol In Vitro. 22:1927–1934.
   PubMed Web of Science ®Google Scholar
• Dhingra N, Shemer A, Correa da Rosa J, Rozenblit M, Fuentes-Duculan J, Gittler JK, Finney R, Czarnowicki T, Zheng X, Xu H, et al. 2014. Molecular profiling of contact dermatitis skin identifies allergen-dependent differences in immune response. J Allergy Clin Immunol. 134:362–372.
   PubMed Web of Science ®Google Scholar
• Dietz L, Bosque A, Pankert P, Ohnesorge S, Merz P, Anel A, Schnolzer M, Thierse HJ. 2009. Quantitative DY-maleimide-based proteomic 2-DE-labeling strategies using human skin proteins. Proteomics. 9:4298–4308.
   PubMed Web of Science ®Google Scholar
• Dietz L, Esser PR, Schmucker SS, Goette I, Richter A, Schnolzer M, Martin SF, Thierse HJ. 2010. Tracking human contact allergens: from mass spectrometric identification of peptide-bound reactive small chemicals to chemical-specific naive human T-cell priming. Toxicol Sci. 117:336–347.
   PubMed Web of Science ®Google Scholar
• Dietz L, Kinzebach S, Ohnesorge S, Franke B, Goette I, Koenig-Gressel D, Thierse HJ. 2013. Proteomic allergen-peptide/protein interaction assay for the identification of human skin sensitizers. Toxicol In Vitro. 27:1157–1162.
   PubMed Web of Science ®Google Scholar
• dos Santos GG, Spiekstra SW, Sampat-Sardjoepersad SC, Reinders J, Scheper RJ, Gibbs S. 2011. A potential in vitro epidermal equivalent assay to determine sensitizer potency. Toxicol In Vitro. 25:347–357.
   PubMed Web of Science ®Google Scholar
• Emter R, Ellis G, Natsch A. 2010. Performance of a novel keratinocyte-based reporter cell line to screen skin sensitizers in vitro. Toxicol Appl Pharmacol. 245:281–290.
   PubMed Web of Science ®Google Scholar
• Esser PR, Wolfle U, Durr C, von Loewenich FD, Schempp CM, Freudenberg MA, Jakob T, Martin SF. 2012. Contact sensitizers induce skin inflammation via ROS production and hyaluronic acid degradation. PLoS One. 7:e41340.
   PubMed Web of Science ®Google Scholar
• European Commission. 2013. Ban on animal testing. Available from: http://ec.europa.eu/growth/sectors/cosmetics/animal-testing/index_en.htm
   Google Scholar
• European Union Reference Laboratories for the European Center for Validation of Alternative Methods. 2015. EURL ECVAM recommendations. Available from: https://eurl-ecvam.jrc.ec.europa.eu/eurl-ecvam-recommendations
   Google Scholar
• Falk K, Lau JM, Santambrogio L, Esteban VM, Puentes F, Rotzschke O, Strominger JL. 2002. Ligand exchange of major histocompatibility complex class II proteins is triggered by H-bond donor groups of small molecules. J Biol Chem. 277:2709–2715.
   PubMed Web of Science ®Google Scholar
• Faulkner L, Meng X, Park BK, Naisbitt DJ. 2014. The importance of hapten-protein complex formation in the development of drug allergy. Curr Opin Allergy Clin Immunol. 14:293–300.
   PubMed Web of Science ®Google Scholar
• Fontenot AP, Falta MT, Kappler JW, Dai S, McKee AS. 2016. Beryllium-induced hypersensitivity: genetic susceptibility and neoantigen generation. J Immunol. 196:22–27.
   PubMed Web of Science ®Google Scholar
• Friedmann PS, Rees J, White SI, Matthews JN. 1990. Low-dose exposure to antigen induces sub-clinical sensitization. Clin Exp Immunol. 81:507–509.
   PubMed Web of Science ®Google Scholar
• Friedmann PS, Sanchez-Elsner T, Schnuch A. 2015. Genetic factors in susceptibility to contact sensitivity. Contact Dermatitis. 72:263–274.
   PubMed Web of Science ®Google Scholar
• Fujita M, Yamamoto Y, Tahara H, Kasahara T, Jimbo Y, Hioki T. 2014. Development of a prediction method for skin sensitization using novel cysteine and lysine derivatives. J Pharmacol Toxicol Methods. 70:94–105.
   PubMed Web of Science ®Google Scholar
• Galbiati V, Mitjans M, Lucchi L, Viviani B, Galli CL, Marinovich M, Corsini E. 2011. Further development of the NCTC 2544 IL-18 assay to identify in vitro contact allergens. Toxicol In Vitro. 25:724–732.
   PubMed Web of Science ®Google Scholar
• Gerberick GF, Troutman JA, Foertsch LM, Vassallo JD, Quijano M, Dobson RL, Goebel C, Lepoittevin JP. 2009. Investigation of peptide reactivity of pro-hapten skin sensitizers using a peroxidase-peroxide oxidation system. Toxicol Sci. 112:164–174.
   PubMed Web of Science ®Google Scholar
• Gerberick GF, Vassallo JD, Bailey RE, Chaney JG, Morrall SW, Lepoittevin JP. 2004. Development of a peptide reactivity assay for screening contact allergens. Toxicol Sci. 81:332–343.
   PubMed Web of Science ®Google Scholar
• Gerberick GF, Vassallo JD, Foertsch LM, Price BB, Chaney JG, Lepoittevin JP. 2007. Quantification of chemical peptide reactivity for screening contact allergens: a classification tree model approach. Toxicol Sci. 97:417–427.
   PubMed Web of Science ®Google Scholar
• Gibbs S, Corsini E, Spiekstra SW, Galbiati V, Fuchs HW, Degeorge G, Troese M, Hayden P, Deng W, Roggen E. 2013. An epidermal equivalent assay for identification and ranking potency of contact sensitizers. Toxicol Appl Pharmacol. 272:529–541.
   PubMed Web of Science ®Google Scholar
• Gibbs S, Spiekstra S, Corsini E, McLeod J, Reinders J. 2013. Dendritic cell migration assay: a potential prediction model for identification of contact allergens. Toxicol in Vitro. 27:1170–1179.
   PubMed Web of Science ®Google Scholar
• Grandea AG, 3rd, Bevan MJ. 1993. A conservative mutation in a class I MHC molecule outside the peptide binding groove stimulates responses to self-peptides. J Immunol. 151:3981–3987.
   PubMed Web of Science ®Google Scholar
• Grilo NM, Antunes AM, Caixas U, Marinho AT, Charneira C, Oliveira MC, Monteiro EC, Marques MM, Pereira SA. 2013. Monitoring abacavir bioactivation in humans: screening for an aldehyde metabolite. Toxicol Lett. 219:59–64.
   PubMed Web of Science ®Google Scholar
• Grotenbreg GM, Nicholson MJ, Fowler KD, Wilbuer K, Octavio L, Yang M, Chakraborty AK, Ploegh HL, Wucherpfennig KW. 2007. Empty class II major histocompatibility complex created by peptide photolysis establishes the role of DM in peptide association. J Biol Chem. 282:21425–21436.
   PubMed Web of Science ®Google Scholar
• Gullo D, Evans JL, Sortino G, Goldfine ID, Vigneri R. 2014. Insulin autoimmune syndrome (Hirata Disease) in European Caucasians taking α-lipoic acid. Clin Endocrinol (Oxf). 81:204–209.
   PubMed Web of Science ®Google Scholar
• Hammond TG, Meng X, Jenkins RE, Maggs JL, Castelazo AS, Regan SL, Bennett SN, Earnshaw CJ, Aithal GP, Pande I, et al. 2014. Mass spectrometric characterization of circulating covalent protein adducts derived from a drug acyl glucuronide metabolite: multiple albumin adductions in diclofenac patients. J Pharmacol Exp Ther. 350:387–402.
   PubMed Web of Science ®Google Scholar
• Hartung T, Rovida C. 2009. Chemical regulators have overreached. Nature. 460:1080–1081.
   PubMed Web of Science ®Google Scholar
• Heiss K, Junkes C, Guerreiro N, Swamy M, Camacho-Carvajal MM, Schamel WW, Haidl ID, Wild D, Weltzien HU, Thierse HJ. 2005. Subproteomic analysis of metal-interacting proteins in human B cells. Proteomics. 5:3614–3622.
   PubMed Web of Science ®Google Scholar
• Hennen J, Aeby P, Goebel C, Schettgen T, Oberli A, Kalmes M, Blomeke B. 2011. Cross talk between keratinocytes and dendritic cells: impact on the prediction of sensitization. Toxicol Sci. 123:501–510.
   PubMed Web of Science ®Google Scholar
• Hooyberghs J, Schoeters E, Lambrechts N, Nelissen I, Witters H, Schoeters G, Van Den Heuvel R. 2008. A cell-based in vitro alternative to identify skin sensitizers by gene expression. Toxicol Appl Pharmacol. 231:103–111.
   PubMed Web of Science ®Google Scholar
• Hopner S, Dickhaut K, Hofstatter M, Kramer H, Ruckerl D, Soderhall JA, Gupta S, Marin-Esteban V, Kuhne R, Freund C, et al. 2006. Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket. J Biol Chem. 281:38535–38542.
   PubMed Web of Science ®Google Scholar
• Illing PT, Vivian JP, Dudek NL, Kostenko L, Chen Z, Bharadwaj M, Miles JJ, Kjer-Nielsen L, Gras S, Williamson NA, et al. 2012. Immune self-reactivity triggered by drug-modified HLA-peptide repertoire. Nature. 486:554–558.
   PubMed Web of Science ®Google Scholar
• Illing PT, Vivian JP, Purcell AW, Rossjohn J, McCluskey J. 2013. Human leukocyte antigen-associated drug hypersensitivity. Curr Opin Immunol. 25:81–89.
   PubMed Web of Science ®Google Scholar
• IPD-IMGT/HLA. Available from: https://www.ebi.ac.uk/ipd/imgt/hla/stats.html
   Google Scholar
• Ito H, Matsushita S, Tokano Y, Nishimura H, Tanaka Y, Fujisao S, Mitsuya H, Hashimoto H, Nishimura Y. 2000. Analysis of T cell responses to the beta 2-glycoprotein I-derived peptide library in patients with anti-beta 2-glycoprotein I antibody-associated autoimmunity. Hum Immunol. 61:366–377.
   PubMed Web of Science ®Google Scholar
• Jameson SC, Bevan MJ. 1995. T cell receptor antagonists and partial agonists. Immunity. 2:1–11.
   PubMed Web of Science ®Google Scholar
• Jankovic V, Remus K, Molano A, Nikolich-Zugich J. 2002. T cell recognition of an engineered MHC class I molecule: implications for peptide-independent alloreactivity. J Immunol. 169:1887–1892.
   PubMed Web of Science ®Google Scholar
• Jenkins MK, Chu HH, McLachlan JB, Moon JJ. 2010. On the composition of the preimmune repertoire of T cells specific for peptide-major histocompatibility complex ligands. Annu Rev Immunol. 28:275–294.
   PubMed Web of Science ®Google Scholar
• Jenkinson C, Jenkins RE, Aleksic M, Pirmohamed M, Naisbitt DJ, Park BK. 2010. Characterization of p-phenylenediamine-albumin binding sites and T-cell responses to hapten-modified protein. J Invest Dermatol. r130:732–742.
   PubMed Web of Science ®Google Scholar
• Johansson H, Albrekt AS, Borrebaeck CA, Lindstedt M. 2013. The GARD assay for assessment of chemical skin sensitizers. Toxicol In Vitro. 27:1163–1169.
   PubMed Web of Science ®Google Scholar
• Josefowicz SZ, Lu LF, Rudensky AY. 2012. Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol. 30:531–564.
   PubMed Web of Science ®Google Scholar
• Kaplan DH, Igyarto BZ, Gaspari AA. 2012. Early immune events in the induction of allergic contact dermatitis. Nat Rev Immunol. 12:114–124.
   PubMed Web of Science ®Google Scholar
• Karlberg AT, Borje A, Duus Johansen J, Liden C, Rastogi S, Roberts D, Uter W, White IR. 2013. Activation of non-sensitizing or low-sensitizing fragrance substances into potent sensitizers - prehaptens and prohaptens. Contact Dermatitis. 69:323–334.
   PubMed Web of Science ®Google Scholar
• Kessler JH, Mommaas B, Mutis T, Huijbers I, Vissers D, Benckhuijsen WE, Schreuder GM, Offringa R, Goulmy E, Melief CJ, et al. 2003. Competition-based cellular peptide binding assays for 13 prevalent HLA class I alleles using fluorescein-labeled synthetic peptides. Hum Immunol. 64:245–255.
   PubMed Web of Science ®Google Scholar
• Kim DE, Yang H, Jang WH, Jung KM, Park M, Choi JK, Jung MS, Jeon EY, Heo Y, Yeo KW, et al. 2015. Predictive capacity of a non-radioisotopic local lymph node assay using flow cytometry, LLNA:BrdU-FCM: Comparison of a cutoff approach and inferential statistics. J Pharmacol Toxicol Methods. 78:76–84.
   PubMed Web of Science ®Google Scholar
• Kimber I, Maxwell G, Gilmour N, Dearman RJ, Friedmann PS, Martin SF. 2012. Allergic contact dermatitis: a commentary on the relationship between T lymphocytes and skin sensitising potency. Toxicology. 291:18–24.
   PubMed Web of Science ®Google Scholar
• Kindt TJ, Goldsby RA, Osborne BA. 2007. Antigens and antibodies. In: Kuby immunology. New York: W.H. Freeman and Company. p. 76–110.
   Google Scholar
• Lancaster AK, Single RM, Solberg OD, Nelson MP, Thomson G. 2007. PyPop update-a software pipeline for large-scale multilocus population genomics. Tissue Antigens. 69:192–197.
   PubMedGoogle Scholar
• Lepoittevin JP. 2006. Metabolism versus chemical transformation or pro- versus prehaptens?. Contact Dermatitis. Feb54:73–74.
   PubMed Web of Science ®Google Scholar
• Lepoittevin JP, Leblond I. 1997. Hapten-peptide-T cell receptor interactions: molecular basis for the recognition of haptens by T lymphocytes. Eur J Dermatol. 7:151–154.
   Web of Science ®Google Scholar
• Lu L, Vollmer J, Moulon C, Weltzien HU, Marrack P, Kappler J. 2003. Components of the ligand for a Ni++ reactive human T cell clone. J Exp Med. 197:567–574.
   PubMed Web of Science ®Google Scholar
• Lythe G, Callard RE, Hoare RL, Molina-Paris C. 2016. How many TCR clonotypes does a body maintain?. J Theor Biol. 389:214–224.
   PubMed Web of Science ®Google Scholar
• Martin SF. 2015. New concepts in cutaneous allergy. Contact Dermatitis. 72:2–10.
   PubMed Web of Science ®Google Scholar
• Martin SF, Esser PR, Schmucker S, Dietz L, Naisbitt DJ, Park BK, Vocanson M, Nicolas JF, Keller M, Pichler WJ, et al. 2010. T-cell recognition of chemicals, protein allergens and drugs: towards the development of in vitro assays. Cell Mol Life Sci. 67:4171–4184.
   PubMed Web of Science ®Google Scholar
• Martin SF, Merfort I, Thierse HJ. 2006. Interactions of chemicals and metal ions with proteins and role for immune responses. Mini Rev Med Chem. 6:247–255.
   PubMed Web of Science ®Google Scholar
• Matsushita S, Takahashi K, Motoki M, Komoriya K, Ikagawa S, Nishimura Y. 1994. Allele specificity of structural requirement for peptides bound to HLA-DRB1*0405 and -DRB1*0406 complexes: implication for the HLA-associated susceptibility to methimazole-induced insulin autoimmune syndrome. J Exp Med. 180:873–883.
   PubMed Web of Science ®Google Scholar
• McDevitt HO. 2000. Discovering the role of the major histocompatibility complex in the immune response. Annu Rev Immunol. 18:1–17.
   PubMed Web of Science ®Google Scholar
• McGeachy MJ, Stephens LA, Anderton SM. 2005. Natural recovery and protection from autoimmune encephalomyelitis: contribution of CD4 + CD25+ regulatory cells within the central nervous system. J Immunol. 75:3025–3032.
   Google Scholar
• McKim JM, Jr., Keller DJ III, Gorski JR. 2012. An in vitro method for detecting chemical sensitization using human reconstructed skin models and its applicability to cosmetic, pharmaceutical, and medical device safety testing. Cutan Ocul Toxicol. 31:292–305.
   PubMed Web of Science ®Google Scholar
• McNamee PM, Api AM, Basketter DA, Gerberick GF, Gilpin DA, Hall BM, Jowsey I, Robinson MK. 2008. A review of critical factors in the conduct and interpretation of the human repeat insult patch test. Regul Toxicol Pharmacol. 52:24–34.
   PubMed Web of Science ®Google Scholar
• Meekins CV, Sullivan TJ, Gruchalla RS. 1994. Immunochemical analysis of sulfonamide drug allergy: identification of sulfamethoxazole-substituted human serum proteins. J Allergy Clin Immunol. 94:1017–1024.
   PubMed Web of Science ®Google Scholar
• Mehling A, Eriksson T, Eltze T, Kolle S, Ramirez T, Teubner W, van Ravenzwaay B, Landsiedel R. 2012. Non-animal test methods for predicting skin sensitization potentials. Arch Toxicol. 86:1273–1295.
   PubMed Web of Science ®Google Scholar
• Meng X, Howarth A, Earnshaw CJ, Jenkins RE, French NS, Back DJ, Naisbitt DJ, Park BK. 2013. Detection of drug bioactivation in vivo: mechanism of nevirapine-albumin conjugate formation in patients. Chem Res Toxicol. 26:575–583.
   PubMed Web of Science ®Google Scholar
• Moudgil KD, Sercarz EE. 2005. Understanding crypticity is the key to revealing the pathogenesis of autoimmunity. Trends Immunol. 26:355–359.
   PubMed Web of Science ®Google Scholar
• Moulon C, Choleva Y, Thierse HJ, Wild D, Weltzien HU. 2003. T cell receptor transfection shows non-HLA-restricted recognition of nickel by CD8+ human T cells to be mediated by alphabeta T cell receptors. J Invest Dermatol. 21:496–501.
   Web of Science ®Google Scholar
• National Institute of Environmental Health Sciences. 2008. Memorandum of understanding on high throughput screening, toxicity pathway profiling, and biological interpretation of findings. Available from: http://www.niehs.nih.gov/about/highlights/assets/docs/memorandum_of_understanding_508.pdf
   Google Scholar
• Natsch A, Bauch C, Foertsch L, Gerberick F, Norman K, Hilberer A, Inglis H, Landsiedel R, Onken S, Reuter H, et al. 2011. The intra- and inter-laboratory reproducibility and predictivity of the KeratinoSens assay to predict skin sensitizers in vitro: Results of a ring-study in five laboratories. Toxicology In Vitro. 25:733–744.
   PubMed Web of Science ®Google Scholar
• Natsch A, Ryan CA, Foertsch L, Emter R, Jaworska J, Gerberick F, Kern P. 2013. A dataset on 145 chemicals tested in alternative assays for skin sensitization undergoing prevalidation. J Appl Toxicol. 33:1337–1352.
   PubMed Web of Science ®Google Scholar
• Nguyen SH, Dang TP, MacPherson C, Maibach H, Maibach HI. 2008. Prevalence of patch test results from 1970 to 2002 in a multi-centre population in North America (NACDG). Contact Dermatitis. 58:101–106.
   PubMed Web of Science ®Google Scholar
• Nilsson AM, Bergstrom MA, Luthman K, Nilsson JL, Karlberg AT. 2005. A conjugated diene identified as a prohapten: contact allergenic activity and chemical reactivity of proposed epoxide metabolites. Chem Res Toxicol. 18:308–316.
   PubMed Web of Science ®Google Scholar
• Norcross MA, Luo S, Lu L, Boyne MT, Gomarteli M, Rennels AD, Woodcock J, Margulies DH, McMurtrey C, Vernon S, et al. 2012. Abacavir induces loading of novel self-peptides into HLA-B*57: 01: an autoimmune model for HLA-associated drug hypersensitivity. AIDS. 26:F21–2F29.
   PubMed Web of Science ®Google Scholar
• Organisation for Economic Co-operation and Development. 1999. Opinion concerning fragrance allergens in cosmetic products; [cited 2016 Feb 5]. Available from: http://ec.europa.eu/health/archive/ph_risk/committees/sccp/documents/out98_en.pdf
   Google Scholar
• Ostrov DA, Grant BJ, Pompeu YA, Sidney J, Harndahl M, Southwood S, Oseroff C, Lu S, Jakoncic J, de Oliveira CA, et al. 2012. Drug hypersensitivity caused by alteration of the MHC-presented self-peptide repertoire. Proc Natl Acad Sci USA. 109:9959–9964.
   PubMed Web of Science ®Google Scholar
• Padovan E, Mauri-Hellweg D, Pichler WJ, Weltzien HU. 1996. T cell recognition of penicillin G: structural features determining antigenic specificity. Eur J Immunol. 26:42–48.
   PubMed Web of Science ®Google Scholar
• Peiser M, Tralau T, Heidler J, Api AM, Arts JH, Basketter DA, English J, Diepgen TL, Fuhlbrigge RC, Gaspari AA, et al. 2012. Allergic contact dermatitis: epidemiology, molecular mechanisms, in vitro methods and regulatory aspects. Current knowledge assembled at an international workshop at BfR, Germany. Cell Mol Life Sci. 69:763–781.
   PubMed Web of Science ®Google Scholar
• Pichler WJ. 2005. Direct T-cell stimulations by drugs-bypassing the innate immune system. Toxicology. 209:95–100.
   PubMed Web of Science ®Google Scholar
• Pirmohamed M, Ostrov DA, Park BK. 2015. New genetic findings lead the way to a better understanding of fundamental mechanisms of drug hypersensitivity. J Allergy Clin Immunol. 36:236–244.
   Web of Science ®Google Scholar
• Politano VT, Api AM. 2008. The Research Institute for Fragrance Materials' human repeated insult patch test protocol. Regul Toxicol Pharmacol. 52:35–38.
   PubMed Web of Science ®Google Scholar
• Popple A, Williams J, Maxwell G, Gellatly N, Dearman RJ, Kimber I. 2016. T lymphocyte dynamics in methylisothiazolinone-allergic patients. Contact Dermatitis. 75:1–13.
   PubMed Web of Science ®Google Scholar
• Python for Population Genomics. 2008. HLA-A alleles. Available from: http://www.pypop.org/popdata/2008/byfreq-A.php
   Google Scholar
• Reisinger K, Hoffmann S, Alepee N, Ashikaga T, Barroso J, Elcombe C, Gellatly N, Galbiati V, Gibbs S, Groux H, et al. 2015. Systematic evaluation of non-animal test methods for skin sensitisation safety assessment. Toxicol In Vitro. 29:259–270.
   PubMed Web of Science ®Google Scholar
• Reuter H, Spieker J, Gerlach S, Engels U, Pape W, Kolbe L, Schmucker R, Wenck H, Diembeck W, Wittern KP, et al. 2011. In vitro detection of contact allergens: development of an optimized protocol using human peripheral blood monocyte-derived dendritic cells. Toxicol In Vitro. 25:315–323.
   PubMed Web of Science ®Google Scholar
• Richter A, Schmucker SS, Esser PR, Traska V, Weber V, Dietz L, Thierse HJ, Pennino D, Cavani A, Martin SF. 2013. Human T cell priming assay (hTCPA) for the identification of contact allergens based on naive T cells and DC-IFN-γ and TNF-α readout. Toxicol In Vitro. 27:1180–1185.
   PubMed Web of Science ®Google Scholar
• Roberts DW, Natsch A. 2009. High throughput kinetic profiling approach for covalent binding to peptides: application to skin sensitization potency of Michael acceptor electrophiles. Chem Res Toxicol. 22:592–603.
   PubMed Web of Science ®Google Scholar
• Rovida C, Alepee N, Api AM, Basketter DA, Bois FY, Caloni F, Corsini E, Daneshian M, Eskes C, Ezendam J, et al. 2015. Integrated testing strategies (ITS) for safety assessment. Altex. 32:25–40.
   PubMedGoogle Scholar
• Rovida C, Hartung T. 2009. Re-evaluation of animal numbers and costs for in vivo tests to accomplish REACH legislation requirements for chemicals – a report by the transatlantic think tank for toxicology (t(4)). Altex. 26:187–208.
   PubMed Web of Science ®Google Scholar
• Rudolph MG, Luz JG, Wilson IA. 2002. Structural and thermodynamic correlates of T cell signaling. Annu Rev Biophys Biomol Struct. 31:121–149.
   PubMedGoogle Scholar
• Saito K, Miyazawa M, Nukada Y, Sakaguchi H, Nishiyama N. 2013. Development of an in vitro skin sensitization test based on ROS production in THP-1 cells. Toxicol In Vitro. 27:857–863.
   PubMed Web of Science ®Google Scholar
• Schmidt M, Raghavan B, Muller V, Vogl T, Fejer G, Tchaptchet S, Keck S, Kalis C, Nielsen PJ, Galanos C, et al. 2010. Crucial role for human toll-like receptor 4 in the development of contact allergy to nickel. Nat Immunol. 11:814–819.
   PubMed Web of Science ®Google Scholar
• Schnuch A, Uter W, Geier J, Lessmann H, Frosch PJ. 2007. Sensitization to 26 fragrances to be labelled according to current European regulation. Results of the IVDK and review of the literature. Contact Dermatitis. 57:1–10.
   PubMed Web of Science ®Google Scholar
• Sharma AM, Klarskov K, Uetrecht J. 2013. Nevirapine bioactivation and covalent binding in the skin. Chem Res Toxicol. 26:410–421.
   PubMed Web of Science ®Google Scholar
• Shoshan SH, Admon A. 2004. MHC-bound antigens and proteomics for novel target discovery. Pharmacogenomics. 5:845–859.
   PubMed Web of Science ®Google Scholar
• Sidney J, Assarsson E, Moore C, Ngo S, Pinilla C, Sette A, Peters B. 2008. Quantitative peptide binding motifs for 19 human and mouse MHC class I molecules derived using positional scanning combinatorial peptide libraries. Immunome Res. 4:2.
   PubMedGoogle Scholar
• Sieben S, Hertl M, Al Masaoudi T, Merk HF, Blomeke B. 2001. Characterization of T cell responses to fragrances. Toxicol Appl Pharmacol. 172:172–178.
   PubMed Web of Science ®Google Scholar
• Simonsson C, Andersson SI, Stenfeldt AL, Bergstrom J, Bauer B, Jonsson CA, Ericson MB, Broo KS. 2011. Caged fluorescent haptens reveal the generation of cryptic epitopes in allergic contact dermatitis. J Invest Dermatol. 131:1486–1493.
   PubMed Web of Science ®Google Scholar
• Solinger AM, Ultee ME, Margoliash E, Schwartz RH. 1979. T-lymphocyte response to cytochrome c. I. Demonstration of a T-cell heteroclitic proliferative response and identification of a topographic antigenic determinant on pigeon cytochrome c whose immune recognition requires two complementing major histocompatibility complex-linked immune response genes. J Exp Med. 150:830–848.
   PubMed Web of Science ®Google Scholar
• Takagi R, Kawano M, Nakamura K, Tsuchida T, Matsushita S. 2016. T-cell responses to tyrosinase-derived self-peptides in patients with leukoderma induced by rhododendrol: implications for immunotherapy targeting melanoma. Dermatology (Basel). 232:44–49.
   PubMed Web of Science ®Google Scholar
• The Adverse Outcome Pathway for Skin Sensitization Initiated by Covalent Binding to Proteins. Available from: http://www.oecd.org/officialdocuments/publicdisplaydocumentpdf/?cote=env/jm/mono(2012)10/part1&doclanguage=en
   Google Scholar
• The US Consumer Product Safety Commission. 2013. CPSC Staff's Strong Snesitizer Guidance Document.
   Google Scholar
• Thierse HJ, Gamerdinger K, Junkes C, Guerreiro N, Weltzien HU. 2005. T cell receptor (TCR) interaction with haptens: metal ions as non-classical haptens. Toxicology. 209:101–107.
   PubMed Web of Science ®Google Scholar
• Thierse HJ, Moulon C, Allespach Y, Zimmermann B, Doetze A, Kuppig S, Wild D, Herberg F, Weltzien HU. 2004. Metal-protein complex-mediated transport and delivery of Ni2+ to TCR/MHC contact sites in nickel-specific human T cell activation. J Immunol. 172:1926–1934.
   PubMed Web of Science ®Google Scholar
• Thyssen JP, Linneberg A, Menne T, Johansen JD. 2007. The epidemiology of contact allergy in the general population-prevalence and main findings. Contact Dermatitis. 57:287–299.
   PubMed Web of Science ®Google Scholar
• Thyssen JP, Menne T. 2010. Metal allergy-a review on exposures, penetration, genetics, prevalence, and clinical implications. Chem Res Toxicol. 23:309–318.
   PubMed Web of Science ®Google Scholar
• Toebes M, Coccoris M, Bins A, Rodenko B, Gomez R, Nieuwkoop NJ, van de Kasteele W, Rimmelzwaan GF, Haanen JB, Ovaa H, et al. 2006. Design and use of conditional MHC class I ligands. Nat Med. 12:246–251.
   PubMed Web of Science ®Google Scholar
• Tong JC, Tan TW, Ranganathan S. 2004. Modeling the structure of bound peptide ligands to major histocompatibility complex. Protein Sci. 13:2523–2532.
   PubMed Web of Science ®Google Scholar
• Unanue ER, Turk V, Neefjes J. 2016. Variations in MHC class II antigen processing and presentation in health and disease. Annu Rev Immunol. 34:265–297.
   PubMed Web of Science ®Google Scholar
• Urbisch D, Mehling A, Guth K, Ramirez T, Honarvar N, Kolle S, Landsiedel R, Jaworska J, Kern PS, Gerberick F, et al. 2015. Assessing skin sensitization hazard in mice and men using non-animal test methods. Regul Toxicol Pharmacol. 71:337–351.
   PubMed Web of Science ®Google Scholar
• van't Land B, Schijf M, van Esch BC, van Bergenhenegouwen J, Bastiaans J, Schouten B, Boon L, Garssen J. 2010. Regulatory T-cells have a prominent role in the immune modulated vaccine response by specific oligosaccharides. Vaccine. 28:5711–5717.
   PubMed Web of Science ®Google Scholar
• van der Veen JW, Rorije E, Emter R, Natsch A, van Loveren H, Ezendam J. 2014. Evaluating the performance of integrated approaches for hazard identification of skin sensitizing chemicals. Regul Toxicol Pharmacol. 69:371–379.
   PubMed Web of Science ®Google Scholar
• Van Regenmortel MH. 2001. Antigenicity and immunogenicity of synthetic peptides. Biologicals. 29:209–213.
   PubMed Web of Science ®Google Scholar
• Vocanson M, Achachi A, Mutez V, Cluzel-Tailhardat M, Varlet BL, Rozieres A, Fournier P, Nicolas JF. 2014. Human T cell priming assay: depletion of peripheral blood lymphocytes in CD25(+) cells improves the in vitro detection of weak allergen-specific T cells. EXS. 104:89–100.
   PubMedGoogle Scholar
• Vocanson M, Hennino A, Rozieres A, Poyet G, Nicolas JF. 2009. Effector and regulatory mechanisms in allergic contact dermatitis. Allergy. 64:1699–1714.
   PubMed Web of Science ®Google Scholar
• Wang XJ, Hayes JD, Wolf CR. 2006. Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents. Cancer Res. 66:10983–10994.
   PubMed Web of Science ®Google Scholar
• Warshaw EM, Maibach HI, Taylor JS, Sasseville D, DeKoven JG, Zirwas MJ, Fransway AF, Mathias CG, Zug KA, DeLeo VA, et al. 2015. North American contact dermatitis group patch test results: 2011-2012. Dermatitis. 26:49–59.
   PubMed Web of Science ®Google Scholar
• Watkins S, Pichler WJ. 2013. Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVbeta20-1, altering pHLA recognition. PLoS One. 8:e76211.
   PubMed Web of Science ®Google Scholar
• Weissler KA, Caton AJ. 2014. The role of T-cell receptor recognition of peptide:MHC complexes in the formation and activity of Foxp3+ regulatory T cells. Immunol Rev. 259:11–22.
   PubMed Web of Science ®Google Scholar
• Weltzien HU, Moulon C, Martin S, Padovan E, Hartmann U, Kohler J. 1996. T cell immune responses to haptens. Structural models for allergic and autoimmune reactions. Toxicology. 107:141–151.
   PubMed Web of Science ®Google Scholar
• Wheatley LM, Plaut M, Schwaninger JM, Banerji A, Castells M, Finkelman FD, Gleich GJ, Guttman-Yassky E, Mallal SA, Naisbitt DJ, et al. 2015. Report from the National Institute of Allergy and Infectious Diseases workshop on drug allergy. J Allergy Clin Immunol. 136:262–271 e262.
   PubMed Web of Science ®Google Scholar
• White JM. 2012. Patch testing: what allergists should know. Clin Exp Allergy. 42:180–185.
   PubMed Web of Science ®Google Scholar
• White KD, Chung WH, Hung SI, Mallal S, Phillips EJ. 2015. Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response. J Allergy Clin Immunol. 136:219–234.
   PubMed Web of Science ®Google Scholar
• Wuillemin N, Adam J, Fontana S, Krahenbuhl S, Pichler WJ, Yerly D. 2013. HLA haplotype determines hapten or p-i T cell reactivity to flucloxacillin. J Immunol. 190:4956–4964.
   PubMed Web of Science ®Google Scholar
• Yamamoto Y, Tahara H, Usami R, Kasahara T, Jimbo Y, Hioki T, Fujita M. 2015. A novel in chemico method to detect skin sensitizers in highly diluted reaction conditions. J Appl Toxicol. 35:1348–1360.
   PubMed Web of Science ®Google Scholar
• Yang H, Na J, Jang WH, Jung MS, Jeon JY, Heo Y, Yeo KW, Jo JH, Lim KM, Bae S. 2015. Appraisal of within- and between-laboratory reproducibility of non-radioisotopic local lymph node assay using flow cytometry, LLNA:BrdU-FCM: comparison of OECD TG429 performance standard and statistical evaluation. Toxicol Lett. 234:172–179.
   PubMed Web of Science ®Google Scholar
• Yun J, Adam J, Yerly D, Pichler WJ. 2012. Human leukocyte antigens (HLA) associated drug hypersensitivity: consequences of drug binding to HLA. Allergy. 67:1338–1346.
   PubMed Web of Science ®Google Scholar
• Yun J, Marcaida MJ, Eriksson KK, Jamin H, Fontana S, Pichler WJ, Yerly D. 2014. Oxypurinol directly and immediately activates the drug-specific T cells via the preferential use of HLA-B*58:01. J Immunol. 192:2984–2993.
   PubMed Web of Science ®Google Scholar
• Yun J, Mattsson J, Schnyder K, Fontana S, Largiader CR, Pichler WJ, Yerly D. 2013. Allopurinol hypersensitivity is primarily mediated by dose-dependent oxypurinol-specific T cell response. Clin Exp Allergy. 43:1246–1255.
   PubMed Web of Science ®Google Scholar
• Zen J, Treutlein HR, Rudy GB. 2001. Predicting sequences and structures of MHC-binding peptides: a computational combinatorial approach. J Comput Aided Mol Des. 15:573–586.
   PubMed Web of Science ®Google Scholar